Wanxia Cai
Impact in
-
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
-
- Cancer-related molecular mechanisms research
Papers in
-
- RNA modifications and cancer 7
- Epigenetics and DNA Methylation 6
- Ubiquitin and proteasome pathways 4
- Cancer-related gene regulation 3
-
- MicroRNA in disease regulation 3
- Co-authors
- Yong Dai (39 shared papers)Donge Tang (39 shared papers)Lianghong Yin (19 shared papers)Zhipeng Zeng (16 shared papers)Dongzhou Liu (10 shared papers)Xiaoping Hong (10 shared papers)Wei Zhang (16 shared papers)Yumei Chen (9 shared papers)
- Journals
- Frontiers in Immunology (7 papers)Frontiers in Oncology (3 papers)ACS Omega (3 papers)Heliyon (3 papers)Journal of Proteomics (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Wanxia Cai
39 papers receiving 298 citations
Peers
Comparison fields: 5 of 68
- Rheumatology 77
- Cancer Research 72
- Immunology 81
- Molecular Biology 165
- Obstetrics and Gynecology 11
Countries citing papers authored by Wanxia Cai
This map shows the geographic impact of Wanxia Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanxia Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanxia Cai more than expected).
Fields of papers citing papers by Wanxia Cai
This network shows the impact of papers produced by Wanxia Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanxia Cai. The network helps show where Wanxia Cai may publish in the future.
Co-authors
The 25 scholars most cited alongside Wanxia Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 41 | |
| 2 | 2022 | 22 | |
| 3 | 2021 | 22 | |
| 4 | 2021 | 18 | |
| 5 | 2021 | 17 | |
| 6 | 2022 | 12 | |
| 7 | 2022 | 11 | |
| 8 | 2022 | 9 | |
| 9 | 2021 | 8 | |
| 10 | 2021 | 8 | |
| 11 | 2022 | 8 | |
| 12 | 2023 | 8 | |
| 13 | 2020 | 8 | |
| 14 | 2021 | 7 | |
| 15 | 2022 | 7 | |
| 16 | 2023 | 7 | |
| 17 | 2022 | 7 | |
| 18 | 2021 | 7 | |
| 19 | 2023 | 7 | |
| 20 | 2022 | 6 |
About Wanxia Cai
Wanxia Cai is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Rheumatology, having authored 41 papers that have together received 301 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (8 papers), RNA modifications and cancer (7 papers), Epigenetics and DNA Methylation (6 papers), Ubiquitin and proteasome pathways (4 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Cancer-related gene regulation (3 papers), Spondyloarthritis Studies and Treatments (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Rheumatology (77 citations), Cancer Research (72 citations), Immunology (81 citations), Molecular Biology (165 citations) and Obstetrics and Gynecology (11 citations). Wanxia Cai has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yong Dai, Donge Tang, Lianghong Yin, Zhipeng Zeng, Dongzhou Liu, Xiaoping Hong, Wei Zhang, Yumei Chen, Weier Dai and Shengyou Liao. Their work appears in journals such as Frontiers in Immunology, Frontiers in Oncology, ACS Omega, Heliyon and Journal of Proteomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.